Professional Documents
Culture Documents
Company
Guidance: No quantitative guidance. Sales for the first eight weeks +49.0% yoy, Store LFL’s
+18.0% yoy and Online +3.0% yoy. Stores reported negative growth in July/August 2022, given 12-mth price performance ($)
lockdowns in NSW and Vic implying a potential return to normalised trading. Positively, July
EBITDA was the highest in 5 years and an additional $10.0m of CODB savings have been 0.90
realised (freight, rent, other costs).
0.77
0.63
Strategy: MOZ is rolling out a “Big Store” strategy which will utilise Rivers. New stores will be
larger format (~1,000 sqm) and house big, well-known brands (Nike, Adidas, Tommy, etc.) as 0.50
well as a streamlined range of other leading brands like Millers, Katies and W. Lane. Big box 0.37
economics are attractive and could deliver EBITDA of $0.5-0.6m annually at a group level or
0.23
~$1.0m pre logistics, deliveries and HO allocation (WILSe). MOZ expects to be able to add 15-20
stores annually and 75 stores in total, which implies potential incremental EBITDA of $45.0m. 0.10
Aug-21 Dec-21 Apr-22 Aug-22
MOZ XAO
Financial summary (Y/E Jun, AUD) FY21A FY22A FY23E FY24E FY25E Key changes 9-Jun After Var %
Sales ($m) 676.8 571.4 624.7 676.5 741.8 Sales FY23E 745.8 624.7 -16%
EBITDA norm ($m) 51.1 (15.7) 31.2 40.8 48.5 ($m) FY24E 766.3 676.5 -12%
Consensus EBITDA ($m) 38.8 45.1 FY25E 789.8 741.8 -6%
EPS growth (%) (122.7) (408.9) (107.2) 189.9 12.1 EBITDA FY23E 46.7 31.2 -33%
EV/EBITDA (x) 0.2 n/m 1.5 0.7 0.2 norm FY24E 54.3 40.8 -25%
P/E (x) 2.6 n/m 11.5 4.0 3.5 ($m) FY25E 55.0 48.5 -12%
FCF yield (%) 371.4 129.5 (43.9) 85.4 44.4 Price target 0.23 0.32 40%
Rating M/W M/W
Source: Company data, Wilsons estimate, Refinitiv.
All amounts are in Australian Dollar (A$) unless otherwise stated.
Catalysts Risks
Interest rate increases (core customer has money in banks), improved Poor Mother’s Day trading period, aggressive discounting by peers and a
online sales/presence and new cost base. rapid decline in broader retail sales and consumer confidence.
P&L ($m) FY21A FY22A FY23E FY24E FY25E Balance sheet ($m) FY21A FY22A FY23E FY24E FY25E
Sales 676.8 571.4 624.7 676.5 741.8 Cash & equivalents 57.8 42.8 19.4 36.9 58.7
EBITDA norm 51.1 (15.7) 31.2 40.8 48.5 Current receivables 1.7 2.5 4.8 5.2 5.7
EBIT norm 33.1 (27.2) 11.7 19.8 25.7 Current inventory 110.1 116.7 91.7 99.7 109.9
PBT norm 23.1 (36.9) 4.3 12.4 22.3 PPE 15.9 10.8 8.7 17.0 23.6
NPAT norm 13.6 (41.5) 3.0 8.7 15.6 Intangibles 20.0 13.3 13.3 13.3 13.3
NPAT reported 2.8 (11.2) 3.0 8.7 15.6 Other assets 160.5 156.4 155.1 151.4 144.7
EPS norm (cents) 12.5 (38.6) 2.8 8.1 9.0 Total assets 366.0 342.5 293.0 323.4 355.9
DPS (cents) 0.0 0.0 0.0 0.0 0.0 Current payables 197.6 201.7 141.4 149.5 155.7
Total debt 31.5 32.9 32.9 32.9 32.9
Growth (%) FY21A FY22A FY23E FY24E FY25E Other liabilities 149.5 145.0 145.0 145.0 145.0
Sales (5.2) (15.6) 9.3 8.3 9.7 Total liabilities 443.2 427.3 366.9 375.0 381.2
EBITDA norm (211.6) (130.7) (298.9) 30.6 19.0 Minorities 0.0 0.0 0.0 0.0 0.0
NPAT norm (122.7) (406.3) (107.2) 189.9 80.2 Shareholders equity (77.2) (84.8) (73.9) (51.6) (25.3)
EPS norm (cents) (122.7) (408.9) (107.2) 189.9 12.1
DPS (cents) n/m n/m n/m n/m n/m Cash flow ($m) FY21A FY22A FY23E FY24E FY25E
Operating cash flow 128.9 44.6 (15.1) 29.4 33.8
Margins and returns (%) FY21A FY22A FY23E FY24E FY25E Maintenance capex 0.0 0.0 0.0 0.0 0.0
EBITDA margin 7.5 (2.7) 5.0 6.0 6.5 Free cash flow 128.9 44.6 (15.1) 29.4 33.8
EBIT margin 4.9 (4.8) 1.9 2.9 3.5 Growth capex (1.8) (4.1) (6.3) (6.3) (6.3)
PBT margin 3.4 (6.5) 0.7 1.8 3.0 Acquisitions/disposals (0.1) (1.3) (1.9) (5.7) (5.7)
NPAT margin 2.0 (7.3) 0.5 1.3 2.1 Dividends paid 0.0 0.0 0.0 0.0 0.0
ROA 9.0 n/m 4.0 6.1 7.2 Other cash flow 0.0 (11.0) 0.0 0.0 0.0
ROIC (31.9) n/m (19.3) (35.6) (50.3) Cash flow pre-financing 127.1 28.2 (23.3) 17.4 21.8
ROE (17.6) n/m (4.1) (16.8) (61.9) Funded by equity 0.0 (1.1) 0.0 0.0 0.0
Funded by cash/debt 29.1 16.1 23.3 (17.4) (21.8)
Interims ($m) 2H21A 1H22A 2H22A 1H23E 2H23E
Sales 332.7 277.6 293.7 334.2 290.5 Liquidity FY21A FY22A FY23E FY24E FY25E
EBITDA norm 6.0 8.0 (23.7) 11.9 19.3 Cash conversion (%) 257.4 (263.0) (20.6) 99.4 90.6
EBIT norm (3.3) 3.3 (30.6) 3.4 8.2 Net debt ($m) (26.4) (9.9) 13.4 (4.0) (25.9)
PBT norm (12.6) 2.0 (38.9) (0.3) 4.5 Net debt / EBITDA (x) (0.5) 0.6 0.4 (0.1) (0.5)
NPAT norm (8.2) (5.1) (36.4) (0.2) 3.2 ND / ND + Equity (%) 25.5 10.5 (22.2) 7.2 50.6
NPAT reported (24.1) 14.3 (25.5) (0.2) 3.2 EBIT / Interest expense (x) 3.3 (2.8) 1.6 2.7 7.6
EPS norm (cents) (8.4) (4.7) (33.6) (0.2) 2.9
DPS (cents) 0.0 0.0 0.0 0.0 0.0 Valuation FY21A FY22A FY23E FY24E FY25E
EV / Sales (x) 0.0 0.0 0.1 0.0 0.0
Stock specific FY21A FY22A FY23E FY24E FY25E EV / EBITDA (x) 0.2 n/m 1.5 0.7 0.2
Store sales growth (%) (17.0) (24.4) 13.7 10.3 11.4 EV / EBIT (x) 0.2 n/m 4.1 1.5 0.3
Online sales growth (%) 25.0 5.7 5.0 5.0 5.0 P / E (x) 2.6 n/m 11.5 4.0 3.5
EziBuy growth (%) 2.5 2.8 2.5 2.5 2.5 P / BV (x) n/m n/m n/m n/m n/m
FCF yield (%) 371.4 129.5 (43.9) 85.4 44.4
Dividend yield (%) 0.0 0.0 0.0 0.0 0.0
Payout ratio (%) 0.0 0.0 0.0 0.0 0.0
Weighted shares (m) 108.5 107.6 107.6 107.6 172.9
Changes to forecasts
We have updated our forecasts to reflect the FY22a result material. Our NPAT forecasts -78.1% (vs. prev.) to
$13.7m driven by the changes below:
• Revenue: -14.5% (vs. prev) to $672.9m, reflecting the following key changes:
o Mozaic Stores: Our forecasts -16.4% (vs. prev.) to $389.2m, as we rebase our revenue per store
forecasts to $0.413m/store. This reflects revenue per store -20.0% vs. FY19a levels as foot
traffic continues to recover for MOZ’s store network.
o Mozaic Online: Our forecasts -26.5% (vs. prev.) to $123.6m, reflecting a normalisation in growth
rates from elevated levels in FY21a. Our forecast imply +5.0% yoy growth in Mozaic Online.
• Gross margins: +137bps (vs. prev.) to 53.1% and provides a partial offset to our revenue downgrades.
Higher gross margins are expected in FY23e given MOZ finished FY22a in a cleaner inventory position.
• CODB: -8.2% (vs. prev.) to $348.6m, largely driven by employee expenses -16.2% (vs. prev.) to $131.2m
reflecting +1.8% yoy growth as MOZ is now starting to see the benefits from the roster optimisation
performed in FY22a. This is offsetting the salary increases to be paid under the retail award (+4.6% yoy).
Definitions at wilsonsadvisory.com.au/disclosures.
| Analyst certification
Each analyst of Wilsons Advisory and Stockbroking Limited (ACN 010 529 665: AFSL 238375) (“Wilsons”) whose name appears in this research
certifies that (1) the recommendations and opinions expressed in this research accurately reflect the analyst’s personal, independent and objective views
about any and all of the subject securities or issuers; (2) no part of the analyst’s compensation was, is, or will be, directly or indirectly, related to the
specific recommendations or views expressed by the analyst in the research; and (3) to the best of the analyst’s knowledge, he/she is not in receipt of
material non-public information about the issuer.
| Disclaimer
This document has been prepared by Wilsons. This communication is not to be disclosed in whole or part or used by any other p arty without Wilsons’
prior written consent. All material presented in this document, unless specifically indicated otherwise, is under copyright to Wilsons. None of the
material, its content, nor any copy of it, may be altered in any way, transmitted to, copied or distributed to any other party, without the prior express
written permission of Wilsons. This document is not directed to, or intended for distribution to or use by, any person or entity who is a citizen or resident
of or located in any locality, state, country or other jurisdiction where such distribution, publication, availability or use would be contrary to law or
regulation or which would subject Wilsons to any registration or licensing requirement within such jurisdiction.
This document is being supplied to you solely for your information and no action should be taken on the basis of or in reliance on this document. To the
extent that any information prepared by Wilsons contains any financial product advice, it is general advice only and has been prepared by Wilsons
without reference to your objectives, financial situation or needs. You should consider the appropriateness of the advice in light of your own objectives,
financial situation and needs before following or relying on the advice. You should also obtain a copy of, and consider, any relevant disclosure document
before making any decision to acquire a financial product. Please refer to Wilsons’ Financial Services Guide for more information:
wilsonsadvisory.com.au/disclosures. Any person, before acting on any advice contained within this communication, should first consult with a Wilsons
investment adviser to assess whether the advice within this communication is appropriate for their objectives, financial situation and needs. Those acting
upon such information without advice do so entirely at their own risk.
This document provided by Wilsons is current as at the date of the issue but may be superseded by future publications. Wilsons assumes no obligation
to update the information or advise on further developments relating to the company or companies covered in this document (“Companies”) or relevant
financial products. Wilsons has not independently verified all of the information given in this document which is provided at a point in time and may not
contain all necessary information about the Companies. Wilsons makes no warranty, express or implied, concerning any information prepared by
Wilsons. Wilsons expressly disclaims (1) any implied warranty of merchantability or (2) fitness for a particular purpose, including any warranty for the
use or the results of the use of any information prepared by Wilson s with respect to their correctness, quality, accuracy, completeness, reliability,
performance, timeliness, or continued availability. Wilsons’ research content should be viewed as an additional investment resource, not as your sole
source of information. To the fullest extent permitted by law Wilsons, its related bodies corporate and their respective officers, directors, employees or
agents, disclaim any and all liabilities for any loss or damage howsoever arising in connection with the use of this document or its contents. Past
performance does not necessarily indicate a financial product’s likely future performance.
This document may contain “forward-looking statements”. Forward-looking statements, opinions and estimates provided in this document are based on
assumptions and contingencies which are outside the control of Wilsons and are subject to change without notice (including but not limited to economic
conditions, market volatility and company-specific fundamentals), and therefore may not be realised in the future.
This report does not constitute an offer or invitation to purchase any securities and should not be relied upon in connection with any contract or
commitment whatsoever.
Wilsons restricts research analysts from trading in securities for which they write research. Other Wilsons employees may hold interests in the company,
but none of those interests are material. Wilsons further advises that at the date of this report, neither Wilsons Advisory and Stockbroking Limited or
Wilsons Corporate Finance Limited have any material interests in the company. Wilsons Corporate Finance Limited ACN 057 547 323, AFSL 238 383
acted as Lead Manager and Underwriter in the May 2018 placement and entitlement offer of Noni B Limited securities and Financial Advisor on the
November 2019 acquisition of EziBuy Limited for which it received fees or will receive fees for acting in this capacity. Wilsons Corporate Finance Limited
ACN 057 547 323, AFSL 238 383 acted as Lead Manager and Underwriter in the September 2021 capital raise of convertible notes of Mosaic Brands
Limited.
Wilsons Advisory and Stockbroking Limited may have a conflict of interest which investors should consider before making an investment decision.
Wilsons Advisory and Stockbroking Limited, Wilsons Corporate Finance Limited and its related bodies corporate trades or may trade as principal in the
securities that are subject of the research report. Wilsons further advises that at the date of this report, neither Wilsons Advisory and Stockbroking
Limited or Wilsons Corporate Finance Limited have any material interests in the company. Wilsons restricts research analysts from trading in securities
for which they write research. Other Wilsons employees may hold interests in the company, but none of those interests are material.
| Wilsons contact
For more information please phone: 1300 655 015 or email: publications@wilsonsadvisory.com.au